1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Prolonged Grief Disorder: new trials by email Literature Review of Prolonged Grief Disorder trials Research Report on Prolonged Grief Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation Dexmedetomidine (IV) 0.5 mcg/kg, Placebo - Abortion, Stillbirth | Phase 2 / Phase 3 | Withdrawn | Stanford University | 2026-07-01 | 2026-07-17 |
Fetal Death (1) · Stillbirth (1) · Stress Disorders, Post-Traumatic (1)
Death (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Mental Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pregnancy Complications (1) · Stress Disorders, Traumatic (1) · Trauma and Stressor Related Disorders (1) · Urogenital Diseases (1)
Dexmedetomidine (1)
United States (1)